VBI Vaccines
VBIV
#10530
Rank
S$2.41 M
Marketcap
S$0.08425
Share price
0.00%
Change (1 day)
-89.76%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): S-$13.65

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is S-$13.08. In 2022 the company made an earnings per share (EPS) of S-$17.03 a decrease over its 2021 EPS that were of S-$10.45.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$13.65
2022S-$17.0362.96%
2021S-$10.4528.57%
2020S-$8.13-54.35%
2019S-$17.80-52.58%
2018S-$37.5410.23%
2017S-$34.0614.29%
2016S-$29.80-62.8%
2015S-$80.1290.68%
2014S-$42.02-7.95%
2013S-$45.65-57.97%
2012S-$108.62-78%
2011S-$493.813151.47%
2010S-$15.1923.87%
2009S-$12.26-18.48%
2008S-$15.0412.08%
2007S-$13.42-49.47%
2006S-$26.56
2005N/A-100%
2004S-$11.8111.94%
2003S-$10.55-81.89%
2002S-$58.24196.44%
2001S-$19.6584.33%
2000S-$10.66-65.37%
1999S-$30.78-29.45%
1998S-$43.6329.61%
1997S-$33.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.23-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S-$5.59-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S-$4.73-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA